FDA broadens Pfizer COVID-19 vaccine EUA to include 12-15 year olds

The Food and Drug Administration today announced the expansion of its emergency use authorization for Pfizer’s COVID-19 vaccine to include adolescents ages 12 to 15. The expansion comes ahead of Wednesday’s convening of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, whose recommendation will be an important part of CDC’s decision on whether to recommend vaccination for that age group.
 
The FDA has updated the Pfizer vaccine-specific Fact Sheets for Healthcare Providers Administering the Vaccine (Vaccination Providers) and for Recipients and Caregivers with information to reflect the use of the vaccine in the adolescent population.